Aspira Pathlab & Diagnostics quarterly results and financials

Aspira Pathlab & Diagnostics (BSE 540788)₹126.95−4.98%(9 Nov 2026 close)Healthcare Service Provider

Key facts

In the Mar 2026 quarter (standalone), Aspira Pathlab & Diagnostics reported sales of ₹6.54 Cr, up 13.0% from Mar 2025, and net profit of −₹0.70 Cr, down 195.9% year on year. For the year to Mar 2026, sales were ₹25.04 Cr and net profit ₹0.06 Cr.

Sales (Mar 2026): ₹6.54 Cr
Net profit (Mar 2026): −₹0.70 Cr
Sales (FY Mar 2026): ₹25.04 Cr
Net profit (FY Mar 2026): ₹0.06 Cr
EPS (Mar 2026): ₹−0.68
Borrowings (Mar 2026): ₹3.33 Cr

Company filings, standalone accounts; latest reported quarter Mar 2026

Aspira Pathlab & Diagnostics quarterly results

₹ crore unless stated; each column is a quarter.

Aspira Pathlab & Diagnostics Quarterly results
	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	2.61	3.33	3.47	3.83	4.65	6.19	5.42	5.79	5.27	8.10	5.13	6.54
Expenses	2.93	3.69	3.84	3.96	4.31	4.85	4.67	4.75	4.45	5.92	6.35	6.88
Operating Profit	−0.33	−0.37	−0.38	−0.14	0.36	1.36	0.77	1.06	0.82	2.20	−1.22	−0.34
OPM %	−12.2%	−10.8%	−10.6%	−3.4%	7.6%	21.9%	14.2%	18.3%	15.5%	27.2%	−23.5%	−5.0%
Other Income	0.11	0.15	0.11	0.09	0.10	0.09	0.10	0.14	0.12	0.15	0.14	0.15
Interest	0.09	0.09	0.08	0.07	0.07	0.07	0.08	0.08	0.08	0.09	0.09	0.09
Depreciation	0.38	0.38	0.37	0.37	0.37	0.35	0.38	0.36	0.36	0.39	0.37	0.39
Profit before tax	−0.72	−0.70	−0.73	−0.50	−0.01	0.98	0.36	0.73	0.45	1.82	−1.57	−0.70
Tax %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net Profit	−0.73	−0.72	−0.75	−0.51	−0.03	1.00	0.39	0.73	0.48	1.85	−1.57	−0.70
EPS (Rs)	−0.71	−0.70	−0.73	−0.50	−0.03	0.97	0.38	0.71	0.47	1.80	−1.53	−0.68

Aspira Pathlab & Diagnostics profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Aspira Pathlab & Diagnostics Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	0.00	0.77	4.37	7.66	8.43	15.25	19.58	14.50	13.23	22.05	25.04	25.04
Expenses	0.24	3.36	8.28	10.92	10.29	11.73	13.21	12.91	14.43	18.50	23.61	23.60
Operating Profit	−0.24	−2.59	−3.89	−3.25	−1.84	3.53	6.40	1.61	−1.19	3.57	1.47	1.46
OPM %	—	−339.4%	−88.9%	−42.3%	−21.7%	23.2%	32.8%	11.2%	−8.9%	16.3%	5.9%	5.8%
Other Income	0.33	0.32	0.23	0.26	0.30	0.21	0.10	0.33	0.43	0.37	0.53	0.56
Interest	0.04	0.25	0.79	0.95	1.00	0.88	0.36	0.41	0.36	0.34	0.38	0.35
Depreciation	0.00	0.19	1.11	1.22	1.65	1.43	1.63	1.58	1.53	1.48	1.53	1.51
Profit before tax	0.05	−2.74	−5.59	−5.19	−4.22	1.38	4.47	−0.10	−2.66	2.09	0.06	0.00
Tax %	24.9%	0.0%	0.0%	0.0%	0.7%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—
Exceptional items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—
Net Profit	0.04	−2.73	−5.59	−5.19	−4.25	1.37	4.47	−0.10	−2.68	2.08	0.06	0.06
EPS (Rs)	0.14	−5.25	−10.76	−6.33	−4.57	1.35	4.34	−0.10	−2.60	2.02	0.06	0.06
Dividend payout %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

Aspira Pathlab & Diagnostics balance sheet

₹ crore, at each year end.

Aspira Pathlab & Diagnostics Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	2.25	2.24	5.18	5.18	8.18	9.27	10.27	10.28	10.28	10.28	10.29	10.28
Reserves	1.37	1.40	0.73	−4.87	−7.95	−10.43	−6.92	−2.44	−2.48	−5.09	−3.02	1.95
Borrowings	0.00	2.63	7.31	11.39	12.55	13.83	7.03	8.87	8.25	7.73	8.15	3.33
Other Liabilities	0.22	0.04	1.66	0.83	2.01	1.66	1.38	1.42	1.30	1.80	2.13	2.97
Total Liabilities	3.84	6.31	14.88	12.53	14.79	14.33	11.76	18.13	17.35	14.72	17.55	18.53
Fixed Assets	0.00	0.03	7.77	7.89	8.87	8.67	7.72	9.54	7.98	6.77	6.51	7.18
CWIP	0.00	0.00	0.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.14	0.00
Other Assets	3.84	6.28	6.85	4.64	5.92	5.66	4.04	8.59	9.37	7.95	10.90	11.35
Inventories	0.00	0.00	0.13	0.38	0.29	0.29	0.38	0.41	0.41	0.46	0.52	0.71
Trade receivables	0.16	0.07	0.10	0.36	0.81	0.61	1.71	4.50	2.35	2.25	2.36	1.74
Cash & equivalents	3.07	5.31	2.80	0.21	0.09	1.09	1.18	1.63	2.34	1.37	2.13	1.67
Total Assets	3.84	6.31	14.88	12.53	14.79	14.33	11.76	18.13	17.35	14.72	17.55	18.53

Aspira Pathlab & Diagnostics cash flow

₹ crore, for each year.

Aspira Pathlab & Diagnostics Cash flow
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	−0.38	−1.30	−4.83	−3.40	−1.88	5.69	2.04	−0.02	1.06	1.89	1.46
Cash from investing activity	−0.01	−10.10	−0.76	−1.96	0.23	−0.08	−0.50	0.15	0.13	0.06	−0.79
Cash from financing activity	2.63	8.89	6.51	3.34	1.26	−2.16	−1.34	−0.93	−0.94	−0.98	−1.13
Net cash flow	2.24	−2.51	0.93	−1.99	−0.34	3.40	0.16	−0.78	0.23	0.94	−0.48
Capex	0.05	7.13	1.01	0.52	0.06	0.31	0.62	0.15	0.27	0.35	0.71
Free cash flow	−0.40	−8.38	−5.79	−3.89	−1.91	5.35	1.41	−0.14	0.78	1.70	0.74
CFO / OP %	139.0%	50.0%	124.0%	105.0%	101.0%	161.0%	32.0%	−1.0%	−89.0%	53.0%	99.0%

Aspira Pathlab & Diagnostics ratios

Working-capital days and returns, by year.

Aspira Pathlab & Diagnostics Ratios
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	—	42	28	37	25	40	83	58	61	38	24
Inventory days	—	314	105	46	52	52	48	59	64	51	58
Days payable	—	731	66	48	74	93	72	52	103	74	93
Cash conversion cycle	—	−374	69	37	4	1	59	66	23	16	−10
Working capital days	—	−2,201	−7	−97	−128	15	68	48	24	13	−5
ROCE %	1.8%	−25.4%	−38.5%	−34.5%	−25.2%	19.8%	35.6%	2.0%	−15.9%	17.3%	2.9%

Aspira Pathlab & Diagnostics: frequently asked questions

What are the latest quarterly results of Aspira Pathlab & Diagnostics?

For the Mar 2026 quarter, Aspira Pathlab & Diagnostics reported sales of ₹6.54 Cr, up 13.0% year on year and net profit of −₹0.70 Cr, down 195.9% year on year. The operating margin was −5.0%.

What is the annual revenue of Aspira Pathlab & Diagnostics?

Aspira Pathlab & Diagnostics' sales for the year to Mar 2026 were ₹25.04 Cr; over the last twelve months they were ₹25.04 Cr.

What is the net profit of Aspira Pathlab & Diagnostics?

Net profit for the year to Mar 2026 was ₹0.06 Cr, and ₹0.06 Cr over the last twelve months. Earnings per share over the same trailing period were ₹0.06.

How much debt does Aspira Pathlab & Diagnostics have?

Aspira Pathlab & Diagnostics reported borrowings of ₹3.33 Cr at Mar 2026, against cash and equivalents of ₹1.67 Cr.

What is the free cash flow of Aspira Pathlab & Diagnostics?

Cash from operations was ₹1.46 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹0.74 Cr.

Loading…